Bill number does not exist. Enter a vaild keyword.
Facebook Twitter Youtube Channels MY MGA

Committee Testimony and Witness Signup

HB1125 - Prescription Drug Monitoring Program – Prescribers of Opioids – Notification Requirement

Health and Government Operations 3/4/2021 1:30:00 PM
As of: 12/8/2021 4:58:38 AM
Name Organization Position Testimony Committee
Delegate Beitzel, Delegate Beitzel FAV Oral Testimony HGO
Doherty, Daniel UNF Opposition to HB 1125 - PDMP - Opioids-Notificatio HGO
Elliott, Robyn UNF 2021 MNA and ACNM HB 1148 House Side.pdf HGO
Wise, Steve UNF HB1125_UNF_MedChi,MDACEP,MDAAP - PDMP - Prescriber HGO
Hames, Shari FAV S.HamesTestimonyHB1125.pdf HGO
Bennardi, Maryland Department of Health /Office of Governmen Maryland Dept. of Health INFO 5 - HGO - HB 1125 - MDH - LOI.pdf HGO
Burrell, Deborah Strengthening the Mid-Atlantic Region for Tomorrow/Burrell International Group FWA HB 1125 SMART Support with Amendments.pdf HGO
Stevens, Kristin Strengthening the Mid-Atlantic Region for Tomorrow (SMART) FWA Oral Testimony
Knight, Kirk The Knight Foundation FAV HB1125.pdf HGO
Galica, Stephanie EBSI FAV LOS_MD 1125_Beitzel_March 2021.pdf HGO
Woodruff, Jon Legislative Analysis and Public Policy Association (LAPPA) INFO Maryland HB 1125.LAPPA testimony.pdf HGO
Beitzell, Wendell FAV LOS HB1125.docx HGO
Click to return on the top page